MGTA Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Benzinga - Mentions: LPTV ACB IMPL BGNE ...

Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session

2 years ago - By: Benzinga - Mentions: HILS TNON XWEL CYN ...

Why Tenon Medical Shares Are Trading Lower By 34%; Here Are 20 Stocks Moving Premarket

2 years ago - By: Kahn Swick & Foti, LLC

MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA

2 years ago - By: Halper Sadeh LLP - Mentions: STSA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA

3 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Magenta Therapeutics, Inc. has obtained a Fair Price in its transaction with Dianthus

3 years ago - By: Kahn Swick & Foti, LLC

MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA

3 years ago - By: Halper Sadeh LLC

MGTA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Magenta Therapeutics, Inc. Is Fair to Shareholders

3 years ago - By: Seeking Alpha

Magenta Therapeutics stock to merge with Dianthus in all-stock deal (NASDAQ:MGTA)

3 years ago - By: Magenta Therapeutics

Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement

3 years ago - By: Seeking Alpha

Magenta stock adopts stockholder rights plan (NASDAQ:MGTA)

3 years ago - By: Magenta Therapeutics

Magenta Therapeutics Adopts Limited Duration Stockholder Rights Plan

3 years ago - By: InvestorPlace - Mentions: RSLS GENE JWN SIDU ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

3 years ago - By: Seeking Alpha

Magenta Therapeutics up 47% on plan to pursue strategic alternatives (NASDAQ:MGTA)

3 years ago - By: Magenta Therapeutics

Magenta Therapeutics to Explore Strategic Alternatives

3 years ago - By: Seeking Alpha

MGTA stock cut to Neutral at Wedbush as leukemia trial comes to a pause (NASDAQ:MGTA)

3 years ago - By: InvestorPlace - Mentions: UTRS MLGO XM BAER ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

3 years ago - By: Seeking Alpha

Magenta Therapeutics pauses leukemia trial following participant death (NASDAQ:MGTA)

3 years ago - By: Magenta Therapeutics

MAGENTA THERAPEUTICS INC (MGTA) Stock News

MGTA Latest News, Press Relases and Analysis

Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Why Tenon Medical Shares Are Trading Lower By 34%; Here Are 20 Stocks Moving Premarket

MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA

Shareholder Alert: Ademi LLP investigates whether Magenta Therapeutics, Inc. has obtained a Fair Price in its transaction with Dianthus

MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA

MGTA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Magenta Therapeutics, Inc. Is Fair to Shareholders

Magenta Therapeutics stock to merge with Dianthus in all-stock deal (NASDAQ:MGTA)

Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement

Magenta stock adopts stockholder rights plan (NASDAQ:MGTA)

Magenta Therapeutics Adopts Limited Duration Stockholder Rights Plan

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Magenta Therapeutics up 47% on plan to pursue strategic alternatives (NASDAQ:MGTA)

Magenta Therapeutics to Explore Strategic Alternatives

MGTA stock cut to Neutral at Wedbush as leukemia trial comes to a pause (NASDAQ:MGTA)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Magenta Therapeutics pauses leukemia trial following participant death (NASDAQ:MGTA)

Magenta Therapeutics Voluntarily Pauses the MGTA-117 Phase 1/2 Dose-Escalation Clinical Trial to Investigate Drug Safety